New Report Links Healthy Ageing and Economic Growth in Super-Ageing Japan

Incentives for health innovation are essential to the sustainability of ageing societies, says the new report from the Global Coalition on Aging and the Health and Global Policy Institute

New York, NY and Tokyo, JAPAN (October 26, 2021) – The Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) today launched a new report identifying incentives for health innovation as a fundamental requirement for economic growth and fiscal sustainability in Japan and other rapidly ageing societies across the Organization for Economic Cooperation and Development (OECD) and worldwide. The new report, Incentivizing Innovation for Healthy Ageing and Economic Growth in Super-Ageing Japan, brings together key insights from a private roundtable hosted in May by the two organizations.

At the May roundtable, sponsored by Pfizer, Japanese and global experts and decision makers concluded that spending on health innovation must be treated as an investment for the fiscal health of the nation. This and other insights from the roundtable report will be at the center of an October 27th roundtable, “Investing in Health Innovation for OECD Ageing Societies: Models for Healthier, Active, and Fiscally Sustainable 21st Century Ageing,” hosted by GCOA and reported to the OECD Forum.

“Incentives for health innovation – strong and sustained intellectual property protections coupled with appropriate access and reimbursement levels of the biomedical innovations themselves – must surely be seen at the center of the economic growth goals for super-ageing societies and all OECD ageing societies,” said Michael W. Hodin, PhD, CEO of the Global Coalition on Aging and the moderator of the roundtable. “Measured by health outcomes, healthier ageing will create the basis for more stable work, productivity, and economic growth environments in ageing societies where transformation to 21st century models are unfolding,” Hodin said.

The roundtable and report connect to the United Nations (UN) Sustainable Development Goals, the UN and World Health Organization Decade of Healthy Ageing, and the OECD promotion of lifelong social participation as a 21stcentury path to achieve healthier and fiscally sound societies. This included discussion of an INES reimbursement proposal (English, Japanese) to support and encourage innovation. Such sentiments were powerfully echoed during the roundtable and reflected in the report.

“Just like we are seeing with climate change, we need the creation of policies in the health sector, too, that could create a virtuous cycle of innovation promotion,” explained Motoshige Itoh, Professor Emeritus University of Tokyo and Professor of International Social Sciences, Gakushuin University, at the roundtable. “This includes incentives to encourage private investment into innovation…strengthened incentives to encourage private investment and reform public frameworks so that resources can be allocated to support innovation.”

The roundtable report offers four key takeaways to support the innovation in health that super-ageing societies and all OECD ageing societies require:

  1. Japan’s health, economic, and social goals align well with global frameworks for healthy ageing found in the UN/WHO Decade of Healthy Ageing and the OECD Strategy for Ageing Societies, especially as Japan moves toward new approaches for work, retirement, and economic growth.
  2. Innovation is integral to the achievement of active ageing goals, and it is important that policies be put into place that actively encourage such innovation. Scientific progress and health innovation are needed in order for every member of Japanese society to enjoy increased healthy longevity.
  3. Innovations in healthy ageing will impact labor markets and therefore the economic and fiscal goals. More people working longer is essential in a society where there are fewer younger people, but this is only possible with healthier ageing that requires investment in the biomedical innovations to enable such healthier ageing.  Short-term spending will yield longer-term savings.
  4. Innovations for Covid-19 vaccines and therapies emerged as a clear example of the need for a hospitable environment for health innovation that is defined by very clear policies in such areas as strong intellectual property rights and market-based access and reimbursement returns.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.